RKDA - Arcadia Biosciences, Inc.
| Previous Close | 4.1700 |
| Open | 4.0300 |
| Bid | 4.1200 x 1100 |
| Ask | 4.3700 x 1300 |
| Day's Range | 3.9700 - 4.1400 |
| 52 Week Range | 1.8200 - 10.2000 |
| Volume | 233,779 |
| Avg. Volume | 269,401 |
| Market Cap | 35.622M |
| Beta (5Y Monthly) | -2.95 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.3030 |
| Earnings Date | Nov 05, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.00 |
- PR Newswire
Arcadia Biosciences Receives U.S. Patent for High Fiber Wheat with Improved Yield
Arcadia Biosciences, Inc., (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced the U.S. Patent and Trademark Office has awarded the company a patent for a yield-improving allele for high fiber, resistant starch wheat. This innovation, which represents the latest patent in Arcadia's GoodWheat™ portfolio of non-genetically modified (non-GM) wheat varieties, was developed through ArcaTech, the company's proprietary technology platform.
- Simply Wall St.
Have Insiders Been Buying Arcadia Biosciences, Inc. (NASDAQ:RKDA) Shares?
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
- American City Business Journals
Davis company's engineered hemp seed presales hit $3 million
Arcadia Biosciences Inc. said it has purchase commitments for $3 million in hemp seeds, just 50 days after launching its uniform hemp seed line.
- PR Newswire
Arcadia Biosciences Announces Over $3 Million in Pre-Season GoodHemp Seed Purchase Commitments
Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced in a letter to shareholders that the company has secured in excess of $3 million in initial seed purchase commitments in just 50 days post launch of its newest product line: GoodHemp. As Arcadia's new commercial brand for delivering genetically superior hemp seeds, transplants, flower and extracts, GoodHemp debuted its first commercial product, a disease resistant, USDA-compliant ultra-low tetrahydrocannabinol (THC) hemp seed, during the American Seed Trade Association CSS & Seed Expo in Chicago.
- Insider Monkey
Hedge Funds Have Never Been More Bullish On Arcadia Biosciences, Inc. (RKDA)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first. This is a necessary first step in our investment process because our research has shown that the elite investors' consensus returns have been exceptional. In the following paragraphs, we find out […]
- Simply Wall St.
Is Arcadia Biosciences (NASDAQ:RKDA) In A Good Position To Invest In Growth?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- American City Business Journals
Arcadia introduces GoodHemp at national seed expo in Chicago
Davis-based Arcadia Biosciences Inc. launched its new GoodHemp product Tuesday at the American Seed Trade Association CSS & Seed Expo in Chicago.
- Benzinga
Arcadia Bio Launches Hemp Seeds Brand: 'Just The Beginning Of Our Ambitions'
The new brand will focus on developing “genetically superior” hemp seeds, transplants, flower and extracts. The first commercial product is a disease-resistant, ultra-low THC hemp seed. “With GoodHemp, we have a disruptive new commercial hemp seed portfolio as well as a rich pipeline of powerful new genetics that solve a major industry problem - hot crops that test above the USDA’s stringent .3 percent THC limit," Sarah Reiter, COO of Arcadia Biosciences, told Benzinga.
- PR Newswire
Arcadia Biosciences Launches GoodHemp, a New Commercial Brand of Superior Hemp Seeds, with an Ultra-Low THC Variety Available for Order this Month
Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced the launch of a new product line: GoodHemp. As the company's new commercial brand for delivering genetically superior hemp seeds, transplants, flower and extracts, GoodHemp will debut its first commercial product, a disease resistant and ultra-low THC hemp seed, during the American Seed Trade Association CSS & Seed Expo on December 11.
- Thomson Reuters StreetEvents
Edited Transcript of RKDA earnings conference call or presentation 6-Nov-19 9:30pm GMT
Q3 2019 Arcadia Biosciences Inc Earnings Call
CNW GroupVEXT Reports 36% Revenue Increase, 7% Increase in Net Income for Year to Date 2019
VEXT Reports 36% Revenue Increase, 7% Increase in Net Income for Year to Date 2019
- PR Newswire
Verdeca Receives Approval of HB4® Drought and Herbicide Tolerant Soybeans in Paraguay
The HB4 stack is Verdeca's newest product release from its pipeline of traits developed to benefit soybean producers through quality improvement, stress mitigation and management practices. "HB4 is a novel soybean trait that enhances the traditional herbicide tolerance package to provide yield stability across diverse environments," said Martin Mariani Ventura, general manager of Verdeca.
- Benzinga
Arcadia Biosciences Falls On Quarterly Net Loss of $14.2M, CEO Says Hemp Research 'More Valuable Than Ever'
The company posted a net loss for the quarter of $14.2 million, or $2.04 per share, representing a 419% decrease from the $4.5-million in net income in the corresponding period in 2018. For the first nine months of 2019, Arcadia reported a net loss of $22.6 million versus a net loss of $12.8 million for the same period in 2018. Larger net losses in both periods was mostly because of the adjustment in the fair value of the common stock warrant and common stock adjustment feature liabilities, the company said in a press release.
- PR Newswire
Arcadia Biosciences Announces Third-Quarter 2019 Financial Results and Business Highlights
-- Company announces plans for hemp seed sales, highlights first GoodWheat™ sales commitments and USDA approval of HB4® soybeans -- DAVIS, Calif. , Nov. 6, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. ...
- American City Business Journals
Arcadia shares rise on GoodWheat contract announcement
Shares in Davis-based Arcadia Biosciences Inc. rose nearly 19% on Tuesday after the seed research company said it has committed buyers for its high-fiber GoodWheat product.
- PR Newswire
Arcadia Biosciences Announces Wheat Purchase Commitment, Significant Increase in GoodWheat™ Harvest Acres
DAVIS, Calif., Nov. 5, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced it has secured its first purchase commitment for its high-fiber bread wheat for 2020 through its North American partner Bay State Milling Company. Earlier this year, Arcadia announced Bay State Milling would be the exclusive North American commercial partner for its high-fiber bread wheat under Bay State Milling's HealthSense™ brand portfolio. "Arcadia's high-fiber wheat technology expands our HealthSense portfolio and strengthens our robust supply chain of identity preserved non-GM wheat varieties," said Peter Levangie, president and CEO of Bay State Milling.
- PR Newswire
Arcadia Biosciences Announces Date of Third-Quarter 2019 Financial Results and Business Highlights Conference Call
DAVIS, Calif. , Oct. 30, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops, today announced that ...
- American City Business Journals
Yolo County continues outdoor ban on high-value crop, to protect cannabis
For at least a while longer, it will be illegal for farmers to grow commercial hemp in the open in Yolo County, even as psychoactive cannabis is legal.
- Simply Wall St.
Did You Manage To Avoid Arcadia Biosciences's (NASDAQ:RKDA) Devastating 85% Share Price Drop?
Arcadia Biosciences, Inc. (NASDAQ:RKDA) shareholders will doubtless be very grateful to see the share price up 71% in...
- Benzinga
Arcadia Biosciences Updates Joint Venture With Archipelago Ventures
Arcadia Biosciences, Inc. (NASDAQ: RKDA) released Tuesday an update on its joint venture with Legacy Ventures Hawaii, Archipelago™ Ventures. It has also brought in a new autoflowering hemp varietal to Hawaii’s pilot program to attain year-round growth cycles. Furthermore, the joint venture has developed mobile extraction and processing equipment to produce THC-free, sun-grown hemp isolate or distillate.
- PR Newswire
Arcadia Biosciences Advances Hemp Operations with Archipelago Ventures
DAVIS, Calif., Oct. 15, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today issued an update on its recently formed joint venture with Legacy Ventures Hawaii, Archipelago™ Ventures. Expanded its cultivation footprint on Hawaii by 3x, from 10 to 30 acres, through partnerships with two new license holders. Archipelago is seeding the new acreage this month and expects to employ both permanent and seasonal staffers locally to execute the research plan involving crop management and harvest of several new varieties.
- PR Newswire
Arcadia Biosciences Granted U.S. Patent for Reduced Gluten GoodWheat
DAVIS, Calif., Sept. 23, 2019 /PRNewswire/ -- Arcadia Biosciences, Inc. (RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced the U.S. Patent and Trademark Office has awarded the company a patent for reduced gluten grains. This unique attribute was developed through Arcadia's in-house breeding platform, which brings novel food innovations to consumers. "This patent reaffirms Arcadia's position as a leader in crop innovation, particularly in optimizing crops for higher nutritional value," said Randy Shultz, Ph.D., vice president of research and development at Arcadia Biosciences.
- Benzinga
Cannabis Deals And M&A Picking Up Steam Again
The Viridian Cannabis Deal Tracker is an information service that monitors capital raise and M&A activity in the legal cannabis industry. Analyzing within 12 key industry sectors, the Viridian Cannabis Deal Tracker provides cannabis companies, investors, and acquirers with the data, trends, and intelligence they need to make informed decisions regarding deal valuations, terms, and structures. Since its inception, the Viridian Cannabis Deal Tracker has tracked and analyzed more than 2,400 capital raises totaling over $29 billion as well as more than 800 M&A transactions.
- Zacks Small Cap Research
RKDA: Initiating Coverage of RKDA: Leveraging Gene-Editing Expertise to Target High Growth Markets
By Brian Marckx, CFA NASDAQ:RKDA | OTC:VAPNF READ THE FULL RKDA RESEARCH REPORT SNAPSHOT: Anticipating Three Key Launches, Steepening Growth Curve Arcadia Biosciences, Inc (NASDAQ:RKDA) is an innovative agricultural company with a broad and growing product portfolio focused largely on improving the nutritional and other valued-added qualities of crops
